We next tested the antitumorigenic activity of the dual PDK1/Aurora kinase inhibitors in vitro by investigating their effect on anchorage-independent growth (3D growth) of pancreatic cancer cells. This evidence concerns the gene PDK1 and familial pancreatic carcinoma.